Skip to main content
Premium Trial:

Request an Annual Quote

Owlstone Medical: Mark Capone

Owlstone Medical has appointed Mark Capone to its board as an independent non-executive director. Capone recently served as president and CEO of Myriad Genetics, and prior to Myriad, he spent 17-years at Eli Lilly in various positions. He is president and CEO of Precision Medicine Advisors and a non-executive board member of Abcam, Micoba Life Sciences, and NephroSant. Following Capone's appointment, the Owlstone Medical board comprises seven members including one executive director and two independent non-executive directors.